MedPath

Supraclavicular Brachial Plexus Block as Opioid Sparing Technique in Pediatrics Undergoing Arteriovenous Fistula Creation

Not Applicable
Recruiting
Conditions
Supraclavicular Brachial Plexus Block
Opioid Sparing
Pediatric
Arteriovenous Fistula
Registration Number
NCT07012616
Lead Sponsor
Tanta University
Brief Summary

This study aims to evaluate the efficacy of supraclavicular brachial plexus block as an opioid-sparing technique in pediatric patients undergoing arteriovenous fistula creation.

Detailed Description

The global incidence of end-stage renal failure (ESRF) is increasing. The preferred procedure for patients with ESRF undergoing maintenance Haemodialysis (HD) is the placement of an arteriovenous fistula (AVF).

In patients with ESRF, brachial plexus block (BPB) is frequently employed to administer anesthesia for the establishment or modification of AVF. This technique offers pain relief, sympathetic blockade, ideal surgical conditions, and a sufficient duration of postoperative block, preventing arterial spasms and graft thrombosis

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Age from 6 to 18 years.
  • Both sexes.
  • American Society of Anesthesiology (ASA) physical status I- III.
  • Undergoing arteriovenous fistula creation under general anesthesia.
Exclusion Criteria
  • Allergy to local anesthetics.
  • Infection at the site of block.
  • Local infection.
  • Coagulation disorder.
  • Previously failed or revision of blocked arteriovenous fistula.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Intraoperative fentanyl consumptionIntraoperatively
Secondary Outcome Measures
NameTimeMethod
Total opioid consumption24 hours postoperatively

Rescue analgesia of 0.5 µg/kg fentanyl will be given if the Wong-Baker score is 4 more.

Time to the 1st rescue analgesia24 hours postoperatively

Time to the first request for the rescue analgesia (time from end of surgery to the first dose of fentanyl administrated) will be assessed.

Degree of pain24 hours postoperatively

Degree of pain will be assessed using Wong-Baker score (0 to 10), 0= no hurt and 10= hurts worst. Wong-Baker score will be assessed at post-anesthesia care unit (PACU), 4, 6, 8, 12, 18 and 24 h postoperatively.

Patient satisfaction24 hours postoperatively

Degree of patient satisfaction will be assessed on a 5-point Likert scale patient satisfaction (1, extremely dissatisfied; 2, unsatisfied; 3, neutral; 4, satisfied; 5, extremely satisfied).

Incidence of adverse events24 hours postoperatively

Incidence of adverse events such as local anesthetic systemic toxicity (LAST), bradycardia, hypotension, PONV, respiratory depression, or any other complication will be recorded.

Trial Locations

Locations (1)

Tanta University

🇪🇬

Tanta, El-Gharbia, Egypt

Tanta University
🇪🇬Tanta, El-Gharbia, Egypt
Mohammed S Elsharkawy, MD
Contact
00201148207870
mselsharkawy@med.tanta.edu.eg
Saad A Moharam, MD
Principal Investigator
Sara M Elghoul, MD
Principal Investigator
© Copyright 2025. All Rights Reserved by MedPath